News
Senzime’s neuromuscular monitoring solution, TetraGraph system receives US patent: Uppsala, Sweden Thursday, July 3, 2025, 16:00 Hrs [IST] Uppsala-headquartered Senzime, a leadi ...
Asahi Kasei Pharma begins phase III study of promising CIPN prevention therapy, Recomodulin to enhance treatment options worldwide: Chelmsford, Massachusetts Thursday, July 3, 202 ...
Hemispherian’s GLIX1 to treat malignant glioma receives US FDA orphan drug designation: Oslo, Norway Thursday, July 3, 2025, 15:00 Hrs [IST] Hemispherian AS, an Oslo-based pharm ...
IDMA Telangana meets DG of Telangana DCA to address key issues facing pharma industry in the state: Our Bureau, Mumbai Thursday, July 3, 2025, 12:10 Hrs [IST] The Telangana State ...
Baar, Switzerland Thursday, July 3, 2025, 12:00 Hrs [IST] ...
Sobi to amend existing agreement with Apellis for ex-US royalties of Aspaveli: Stockholm, Sweden Thursday, July 3, 2025, 13:00 Hrs [IST] Sobi, a global biopharma company, announce ...
HanchorBio signs licensing agreement with Shanghai Henlius Biotech to develop and commercialise rights to HCB101 across Greater China: Taipei, Shanghai Thursday, July 3, 2025, 11: ...
Rahway, New Jersey Thursday, July 3, 2025, 09:00 Hrs [IST] ...
The 9th Tamil Nadu state pharmacy council election concluded on Wednesday morning, July 2nd, with the returning officer announcing the results in the afternoon. Six candidates who secured the highest ...
BioVersys & Shionogi ink global research collaboration for broad-spectrum NTM clinical candidate: Basel, Switzerland Thursday, July 3, 2025, 10:00 Hrs [IST] BioVersys AG, a multi- ...
DGFT extends minimum import price on soda ash imports till December 2025 to ensure fair trade: Shardul Nautiyal, Mumbai Thursday, July 3, 2025, 08:00 Hrs [IST] In its continued ef ...
NCAHP recommends switching term from "Paramedical" to "Allied and Healthcare" for uniformity: Our Bureau, New Delhi Thursday, July 3, 2025, 08:00 Hrs [IST] The National Commission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results